Scarica l'app Stockscreener
2.41
1.69%
0.04
Dopo l'orario di chiusura:
2.43
0.02
+0.83%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$2.37
Aprire:
$2.38
Volume 24 ore:
121.38K
Relative Volume:
1.38
Capitalizzazione di mercato:
$98.82M
Reddito:
$2.70M
Utile/perdita netta:
$5.53M
Rapporto P/E:
21.91
EPS:
0.11
Flusso di cassa netto:
$-10.55M
1 W Prestazione:
-1.23%
1M Prestazione:
+3.43%
6M Prestazione:
+13.15%
1 anno Prestazione:
+1.47%
Intervallo 1D:
$2.31
$2.4698
Intervallo di 1 settimana:
$2.31
$2.51
Portata 52W:
$1.82
$3.09
Oramed Pharmaceuticals Inc Stock (ORMP) Company Profile
Nome
Oramed Pharmaceuticals Inc
Settore
Industria
Telefono
646-844-1164
Indirizzo
1185 AVENUE OF THE AMERICAS, 3RD FLOOR, NEW YORK, NY
Confronta ORMP con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ORMP
Oramed Pharmaceuticals Inc
|
2.41 | 97.18M | 2.70M | 5.53M | -10.55M | 0.11 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.79 | 106.37B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
460.46 | 59.90B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
564.63 | 60.40B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
796.92 | 49.56B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.10 | 36.88B | 4.56B | -176.77M | 225.30M | -1.7177 |
Oramed Pharmaceuticals Inc Stock (ORMP) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2023-01-12 | Downgrade | Canaccord Genuity | Buy → Hold |
| 2022-02-18 | Iniziato | Cantor Fitzgerald | Overweight |
| 2021-04-20 | Iniziato | Canaccord Genuity | Buy |
| 2021-02-09 | Iniziato | National Securities | Buy |
| 2020-12-03 | Iniziato | Alliance Global Partners | Buy |
| 2020-03-11 | Iniziato | Aegis Capital | Buy |
| 2019-09-11 | Iniziato | Ladenburg Thalmann | Buy |
| 2017-12-11 | Ripresa | B. Riley FBR, Inc. | Buy |
| 2016-05-26 | Reiterato | FBR Capital | Outperform |
| 2015-12-01 | Reiterato | H.C. Wainwright | Buy |
| 2015-11-19 | Iniziato | FBR Capital | Outperform |
| 2015-04-13 | Ripresa | MLV & Co | Buy |
| 2014-01-30 | Reiterato | Aegis Capital | Buy |
| 2014-01-08 | Reiterato | Aegis Capital | Buy |
| 2014-01-08 | Iniziato | MLV & Co | Buy |
| 2013-12-03 | Iniziato | Aegis Capital | Buy |
Mostra tutto
Oramed Pharmaceuticals Inc Borsa (ORMP) Ultime notizie
Oramed Pharmaceuticals Forms Golden Cross, Signaling Bullish Breakout Ahead - Markets Mojo
Oramed Pharmaceuticals Inc. stock outlook for YEARStop Loss & Expert Verified Movement Alerts - newser.com
Will Oramed Pharmaceuticals Inc. stock go up soonJuly 2025 Snapshot & Smart Allocation Stock Tips - newser.com
What’s the recovery path for long term holders of Oramed Pharmaceuticals Inc.2025 Technical Overview & Real-Time Buy Signal Alerts - newser.com
Weiss Ratings Reaffirms Sell (D) Rating for Oramed Pharmaceuticals (NASDAQ:ORMP) - MarketBeat
Analyzing recovery setups for Oramed Pharmaceuticals Inc. investorsGold Moves & Free AI Powered Buy and Sell Recommendations - newser.com
How to track smart money flows in Oramed Pharmaceuticals Inc.July 2025 Pullbacks & Weekly Market Pulse Updates - newser.com
Will Oramed Pharmaceuticals Inc. stock outperform Dow Jones index2025 Sector Review & Safe Capital Preservation Plans - newser.com
Is Oramed Pharmaceuticals Inc. stock affected by interest rate hikesWeekly Trade Summary & AI Optimized Trading Strategy Guides - newser.com
How supply chain issues affect Oramed Pharmaceuticals Inc. stockJuly 2025 Levels & Low Drawdown Momentum Ideas - newser.com
Is Oramed Pharmaceuticals Inc OJU1 a good long term investmentPrice Volatility Patterns & Free Double Digit Growth Tips - earlytimes.in
What analysts say about Oramed Pharmaceuticals Inc stockEarnings Season Recap & Small Budget Wealth Building - earlytimes.in
Oramed Pharmaceuticals completes first tranche of Scilex warrant repurchase - Investing.com
Oramed Pharm Completes Warrant Repurchase Agreement - TipRanks
How to forecast Oramed Pharmaceuticals Inc. trends using time seriesQuarterly Earnings Summary & Community Supported Trade Ideas - newser.com
What MACD signals say about Oramed Pharmaceuticals Inc.Weekly Trade Recap & Intraday High Probability Alerts - newser.com
Can Oramed Pharmaceuticals Inc. (OJU1) stock withstand sector downturnsSell Signal & Safe Entry Point Identification - newser.com
Can Oramed Pharmaceuticals Inc. stock attract ESG capital inflowsEarnings Risk Report & Free Community Supported Trade Ideas - newser.com
What institutional flow reveals about Oramed Pharmaceuticals Inc.2025 Market Overview & Free Accurate Trade Setup Notifications - newser.com
Oramed Pharmaceuticals Inc. (NASDAQ:ORMP) Short Interest Down 35.7% in September - MarketBeat
Will Oramed Pharmaceuticals Inc. bounce back from current supportWeekly Volume Report & Verified Stock Trade Ideas - newser.com
Can Oramed Pharmaceuticals Inc. stock deliver surprise earnings beatMarket Movers & Fast Exit Strategy with Risk Control - newser.com
Has Oramed Pharmaceuticals Inc. found a price floorJuly 2025 Pullbacks & Real-Time Chart Pattern Alerts - newser.com
Analyzing net buyer seller activity in Oramed Pharmaceuticals Inc.Buy Signal & Technical Pattern Based Signals - newser.com
Using RSI to spot recovery in Oramed Pharmaceuticals Inc.2025 Short Interest & Real-Time Volume Triggers - newser.com
Will Oramed Pharmaceuticals Inc. stock see PE expansionTrade Analysis Summary & Daily Profit Maximizing Tips - newser.com
Oramed Pharmaceuticals (ORMP) Receives $13 Million from Scilex f - GuruFocus
Oramed Pharmaceuticals Inc Azioni (ORMP) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
5.74%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):